Jenburkt Pharmaceuticals Share Price

Jenburkt Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2024.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 48.98 Crore, up 9.24 % from last quarter Total Income of Rs 44.84 Crore and up 14.10 % from last year same quarter Total Income of Rs 42.93 Crore. Company has reported net profit after tax of Rs 10.85 Crore in latest quarter.

The company’s top management includes Mr.Ashish U Bhuta, Mr.Dilip H Bhuta, Mrs.Hina R Mehta, Mr.Krishnan Subharaman, Mr.Pankaj A Dantwala, Mr.Sumit A Thakkar, Mr.Ashish R Shah. Company has D R Mehta & Associates as its auditors. As on 31-03-2026, the company has a total of .44 Crore shares outstanding.

Jenburkt Pharma Share Price Today is Rs. 1140.90. On previous day, the Jenburkt Pharma Share Price (NSE) closed at Rs. 1178.3, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 46.64% of the stake in Jenburkt Pharma shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Jenburkt Pharma stocks was 1.38% as compared to 1.38% in Dec 2025 with decrease of 0.41%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.12% as compared to 0.12% in Dec 2025 with decrease of 0.0%. Out of the total DII holdings in Jenburkt Pharma shares 0.0% was held by mutual funds. The rest including public held is 51.86%. Jenburkt Pharma stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Jenburkt Pharma Dividend: Ever since 1985, Jenburkt Pharma dividends has been paid out around 30 times. As on 19 Jun, 2026, 03:58 PM IST, The overall dividend yield for Jenburkt Pharma stands at 1.75%. The last dividend paid was on July 11, 2025 (Rs. 18.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 78.71.

Jenburkt Pharma Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 48.98 Cr. of sales and 9.24% of quarterly net profit, there have been multiple ups and downs in the Jenburkt Pharma stock prices in the past few weeks. For example, Jenburkt Pharma stock price on 12th of June 2026 was around Rs. 1187.45. Jenburkt Pharma share price now stands at an average of Rs. 1140.90. Judging by last week's performance, stock is in down trend.

Jenburkt Pharma has a median target price of Rs. 1370.0 in 12 months by 1 analysts. They have provided a high estimate of Rs. 1370.0 and low estimate of Rs. 1370.0 for Jenburkt Pharma share.

Historical Prices and Performance:
Jenburkt Pharma, incorporated in 1985 is a Small Cap company (with a market cap of Rs. 503.51) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Jenburkt Pharma stock was 17.62%, 18.66%, 17.92%, 20.1% and 18.99% respectively.
The Jenburkt Pharma share gave a 3 year return of 65.68% as compared to Nifty 50 which gave a return of 28.03%.
Jenburkt Pharma announced 180.0% final dividend on July 11, 2025.

Key Metrics:
PE Ratio of Jenburkt Pharma is 14.99
Prices/Sales Ratio of Jenburkt Pharma is 2.5
Price/Book Ratio of Jenburkt Pharma is 2.64

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. The PE ratio and PB Ratio of the company are among its competitors stand at 14.99 and 2.64 respectively.

Leadership of Jenburkt Pharma :
Ashish R Shah is Co. Secretary & Compl. Officer
Ashish U Bhuta is Chairman & Managing Director
Dilip H Bhuta is WholeTime Director & CFO
Hina R Mehta is Ind. Non-Executive Director
Sumit A Thakkar is Ind. Non-Executive Director
Krishnan Subharaman is Ind. Non-Executive Director
Pankaj A Dantwala is Ind. Non-Executive Director